From: Obesity can influence children’s and adolescents’ airway hyperresponsiveness differently
All AHR subjects (PD20<2400 μg) | Subjects with moderate/severe AHR(PD20<400 μg) | Subjects with borderline AHR (PD20>400 μg) | Subjects with normal reactivity | |||||
---|---|---|---|---|---|---|---|---|
β | p | β | p | β | p | β | p | |
FVC% (All) | 0,161 | 0,123 | 0,167 | 0,293 | 0,239 | 0,217 | 0,227 | 0,353 |
FEV1% (All) | −0,077 | 0,410 | −0,105 | 0,473 | −0,168 | 0,326 | −0,087 | 0,690 |
FEV1/FVC (All) | 0,099 | 0,383 | 0,131 | 0,463 | 0,132 | 0,523 | 0,187 | 0,469 |
FVC% (Males) | 0.053 | 0.730 | 0.086 | 0.611 | 0.107 | 0.748 | 0.158 | 0.615 |
FEV1% (Males) | 0.010 | 0.942 | −0.007 | 0.962 | −0.056 | 0.851 | −0.033 | 0.905 |
FEV1/FVC (Males) | 0.001 | 0.994 | 0.035 | 0.855 | 0.046 | 0.895 | 0.126 | 0.707 |
FVC% (Females) | 0.411 | 0.027 | 0.934 | 0.035 | 0.390 | 0.015 | 0.240 | 0.471 |
FEV1% (Females) | −0.348 | 0.036 | −0.849 | 0.036 | −0.315 | 0.024 | −0.095 | 0.744 |
FEV1/FVC (Females) | 0.290 | 0.147 | 0.882 | 0.059 | 0.075 | 0.665 | 0.195 | 0.575 |
FVC% (Age ≤13) | −0,060 | 0,725 | −0,038 | 0,803 | 0,094 | 0,927 | −0,177 | 0,713 |
FEV1% (Age ≤13) | 0,112 | 0,469 | 0,099 | 0,485 | −0,054 | 0,953 | 0,225 | 0,611 |
FEV1/FVC (Age ≤13) | −0,189 | 0,314 | −0,127 | 0,470 | −0,223 | 0,825 | −0,173 | 0,720 |
FVC% (Age>13) | 0,174 | 0,261 | 0,260 | 0,327 | 0,124 | 0,525 | 0,144 | 0,561 |
FEV1% (Age>13) | −0,119 | 0,399 | −0,193 | 0,438 | −0,084 | 0,633 | −0,023 | 0,916 |
FEV1/FVC (Age>13) | 0,108 | 0,523 | 0,228 | 0,444 | 0,015 | 0,944 | 0,070 | 0,790 |